Profil Institut für Stoffwechselforschung GmbH
47
2
2
37
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
17.0%
8 terminated/withdrawn out of 47 trials
82.2%
-4.3% vs industry average
9%
4 trials in Phase 3/4
8%
3 of 37 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (47)
CK-0045 Proof-of-concept Study in Participants With Overweight / Obesity and Type 2 Diabetes
Role: collaborator
Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
Role: collaborator
Comparison Study of Insulin GZR4 With Insulin Degludec
Role: collaborator
A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide
Role: collaborator
A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
Role: collaborator
Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)
Role: collaborator
Clinical Experimental Study to Investigate Specific Features of ClampArt®
Role: lead
Comparison of the Pharmacokinetic and Pharmacodynamic Properties of Biocon's Insulin R U-500 With Humulin® R U-500 (US Reference Product) in Healthy Subjects
Role: collaborator
Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil
Role: collaborator
Explorative Assessment of Biomarkers in Overweight and Obese Subjects
Role: lead
Validation of the Doubly Labelled Water Method in Subjects With Type 2 Diabetes Mellitus
Role: lead
Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R
Role: collaborator
Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients
Role: lead
A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM
Role: collaborator
Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes Mellitus
Role: collaborator
Empagliflozin and Sympathetic Nerve Traffic
Role: lead
Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal
Role: collaborator
Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus
Role: collaborator
Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30
Role: collaborator
Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N
Role: collaborator